Process of producing aligned permanent magnets
    11.
    发明授权
    Process of producing aligned permanent magnets 失效
    生产对准永磁体的工艺

    公开(公告)号:US4897283A

    公开(公告)日:1990-01-30

    申请号:US70634

    申请日:1987-07-06

    CPC classification number: H01F1/0551 C23C4/134

    Abstract: A highly aligned rare-earth transition metal alloy magnet material such as samarium-cobalt (SmCo.sub.5). The high degree of alignment is evidenced by an isolated X-ray diffraction pattern peak for Cu.sub.k.alpha. radiation at a interplane "d" spacing of 2.0 A.degree. and is produced by very high temperature deposition of the material on a hot surface. The surface temperature is maintained well above 800 degrees centigrade and most preferably is initially set at approximately 1020 degrees centigrade or higher at which temperature the isolated diffraction pattern peak dominates. A higher temperature typically occurs during deposition. Deposition of the material on the surface typically takes place by application of the material as a fine, homogeneously sized powder to the plasma flame of a plasma torch. The surface may be preheated by the application of the plasma flame to the surface without the application of the powdered material. A feedback controlled auxiliary heat source may also be used to facilitate maintaining the temperature of the surface at the very high temperature level.

    Abstract translation: 高度对齐的稀土过渡金属合金磁铁材料如钐钴(SmCo5)。 通过在2.0“的平面”d“间距处的Cukα辐射的孤立X射线衍射图峰,证明了高度的对准,并且通过材料在热表面上的非常高温度的沉积而产生。 表面温度保持在800摄氏度以上,最优选最初设定在约1020摄氏度或更高,在该温度下,分离的衍射图谱峰值占主导地位。 沉积期间通常会发生较高的温度。 材料沉积在表面上通常是通过将这种材料作为精细的均匀尺寸的粉末施加到等离子体焰炬的等离子火焰中而进行的。 可以通过将等离子体火焰施加到表面而不施加粉末材料来预热表面。 还可以使用反馈控制的辅助热源来促进将表面的温度保持在非常高的温度水平。

    Beryllium based, wear-resistant material for bearings and the like
    13.
    发明授权
    Beryllium based, wear-resistant material for bearings and the like 失效
    铍基,轴承用耐磨材料等

    公开(公告)号:US4754494A

    公开(公告)日:1988-06-28

    申请号:US756751

    申请日:1985-07-18

    Applicant: Kaplesh Kumar

    Inventor: Kaplesh Kumar

    Abstract: A gas bearing and bearing surfaces capable of operating in an unlubricated configuration and providing reliable wear-resistant, start/stop cycling. The bearing typically comprises opposed surfaces of the same or different materials. A first surface is typically formed by ion implantation of boron into a beryllium metal bearing structure. The boron is typically implanted at a predetermined depth into the beryllium surface to provide a substantially pure beryllium surface. The second surface is typically PYROCERAM, a ceramic metal composite, such as a titanium diboride beryllium structure or a surface having titanium diboride and beryllium applied to a beryllium metal bearing structure by hot isostatic pressing facing. The second surface is adapted to run against the first, or against itself in the ceramic or ceramic surface case. The bearing configuration is capable of running reliably and with acceptably low wear through many start/stop cycles without the application of any lubricant. The titanium diboride, beryllium composite applied to a beryllium substrate finds further application such as in wear or impact-resistant surfaces.

    Abstract translation: 气体轴承和轴承表面,能够以非润滑配置运行,并提供可靠的耐磨,起动/停止循环。 轴承通常包括相同或不同材料的相对表面。 通常通过将硼离子注入铍金属承载结构中来形成第一表面。 硼通常以预定深度注入铍表面以提供基本上纯的铍表面。 第二表面通常是PYROCERAM,一种陶瓷金属复合材料,例如二硼化钛铍结构或具有二硼化钛和铍的表面,其通过热等静压面对而施加到铍金属承载结构。 第二表面适于在陶瓷或陶瓷表面壳体中抵靠第一表面或与其本身相抵触。 轴承配置能够通过许多启动/停止循环而可靠地运行并具有可接受的低磨损,而不需要使用任何润滑剂。 应用于铍底物的二硼化钛,铍复合物可进一步应用于耐磨损或耐冲击表面。

    Age hardened beryllium alloy and cermets
    14.
    发明授权
    Age hardened beryllium alloy and cermets 失效
    老化铍合金和金属陶瓷

    公开(公告)号:US4306907A

    公开(公告)日:1981-12-22

    申请号:US136599

    申请日:1980-09-12

    CPC classification number: C22C32/0036 C22C32/0047 Y10S75/951

    Abstract: Process for the formation of precipitation hardened beryllium-nickel, beryllium-iron, and beryllium-cobalt alloys and cermets for structural and bearing use respectively in precision instruments and such alloys and cermets. A beryllium-nickel, -iron, or -cobalt high solute solution at elevated temperature is rapidly cooled to provide a readily machined solid solution. After machining, the alloy is reheated to an intermediate temperature under controlled conditions where precipitation hardening occurs through limited precipitate cluster formation. A cermet is formed in the process with the addition of a ceramic material to the beryllium alloy in the initial steps.

    Abstract translation: 在精密仪器和这种合金和金属陶瓷中分别形成用于结构和轴承使用的沉淀硬化的铍镍,铍 - 铁和铍 - 钴合金和金属陶瓷的方法。 在高温下将铍镍,铁或钴高溶质溶液快速冷却以提供容易加工的固溶体。 加工后,在控制条件下将合金再加热至中间温度,通过有限的沉淀聚集形成沉淀硬化。 在该步骤中,在铍合金中添加陶瓷材料,形成金属陶瓷。

    Process of making permanent magnets
    15.
    发明授权
    Process of making permanent magnets 失效
    制造永磁体的工艺

    公开(公告)号:US4297388A

    公开(公告)日:1981-10-27

    申请号:US138650

    申请日:1980-04-08

    CPC classification number: H01F41/14 C23C4/134 H01F1/0551 H01F1/066

    Abstract: Process and apparatus for forming plasma sprayed high density, high coercivity permanent magnet material and permanent magnets formed therefrom. The plasma sprayed permanent magnet material is obtained in a substantially amorphous state resulting from specifically controlled plasma spray parameters. The amorphous deposition possesses high coercivity, density and potential residual magnetism. The as-sprayed magnetic material is preferably heat treated and then densified to nearly maximum theoretical density. The amorphous structure permits retention of substantially all of the coercivity after heat treatment as well as densification to well over 95% of maximum theoretical density. In addition, magnetic materials, preferably fabricated in accordance with this plasma spraying technique as an amorphous deposit of permanent magnet material, are aligned in a magnetic field and thermally aged to produce permanent magnets in the presence of a thermal gradient or mechanical strain resulting in a high coercivity permanent magnet. Controlled crystalline deposits may also be utilized as the starting material for fabrication of the aligned magnets. The invention has application primarily with the use of permanent magnets formed of rare earth-cobalt alloys and in particular of samarium-cobalt alloys.

    Abstract translation: 用于形成等离子体喷涂的高密度,高矫顽力永磁体材料和由其形成的永磁体的方法和装置。 等离子体喷涂的永久磁铁材料是由特殊控制的等离子体喷涂参数得到的,基本上是无定形的。 无定形沉积具有高的矫顽力,密度和潜在的剩余磁性。 喷涂的磁性材料优选被热处理,然后致密化到几乎最大的理论密度。 无定形结构允许在热处理之后保持基本上所有的矫顽力以及致密化至超过理论密度的95%以上。 此外,优选地根据这种等离子体喷涂技术制造的磁性材料作为永久磁铁材料的无定形沉积物,在磁场中对准并热老化,以在存在热梯度或机械应变的情况下产生永磁体,导致 高矫顽力永磁体。 受控的结晶沉积物也可以用作制造对准的磁体的起始材料。 本发明主要应用于由稀土 - 钴合金,特别是钐钴合金形成的永磁体。

    Differential expansion volume compaction
    16.
    发明授权
    Differential expansion volume compaction 失效
    差分膨胀体积压实

    公开(公告)号:US4260582A

    公开(公告)日:1981-04-07

    申请号:US58530

    申请日:1979-07-18

    CPC classification number: B30B1/005 B22F3/14 H01F41/0266 H01F41/0273

    Abstract: Method and apparatus for the formation of a molded article from powders and powder compacts of a material by pressure compaction of the powders under the influence of a thermally driven differential volume expansion of first and second elements constraining the powders. The volume expansion achieves a trippling of the compaction effect.

    Abstract translation: 用于通过在受限制粉末的第一和第二元件的热驱动的差动体积膨胀的影响下粉末的压力压制从粉末和材料的粉末压块形成模制品的方法和装置。 体积膨胀实现了压实效应的跳闸。

    Building resilience to Covid-19 and its variants

    公开(公告)号:US11877584B2

    公开(公告)日:2024-01-23

    申请号:US17236990

    申请日:2021-04-21

    Applicant: Kaplesh Kumar

    Inventor: Kaplesh Kumar

    CPC classification number: A23L33/30 G16H20/30

    Abstract: Method of building resistance to Covid-19 disease development. The strong link between the distribution of Covid-19 disease (CV) severity across the United States population and that of systemic inflammation, as indicated in the individual's C-reactive protein (CRP) level, explains the widely varied symptomatic responses of individuals afflicted with the virus. The data are consistent with the fewer infections and deaths reported for the Asian countries. The disease pathologies of CV and non-specific interstitial pneumonia (NSIP) patients bear close similarities. Modeling the disease as a chemically reactive process indicates that the virus catalyzes the inflammation driven reaction, causing lung infiltration and injury, up to and including patient death. Prevention methods involving exercise and diet successfully applied for lung stabilization in NSIP also apply to CV mitigation, the goal of which is to achieve pre-disease CRP levels of

    Pulmonary interstitial pneumonia treatment

    公开(公告)号:US10052336B2

    公开(公告)日:2018-08-21

    申请号:US15428595

    申请日:2017-02-09

    Applicant: Kaplesh Kumar

    Inventor: Kaplesh Kumar

    CPC classification number: A61K31/573 A61K31/52 A61K31/616 A61K2300/00

    Abstract: Model and method of treating inflammatory diseases. Traditional treatments for such diseases include administering to the patient toxic anti-inflammatory drugs. Following stabilization of the symptoms, the drug doses are tapered down to minimize side effects, as a result of which inflammation remains high and the disease is rarely cured. A chemistry-based disease model concludes that irrespective of the role that inflammation plays in the disease, inflammation reduction will impede disease initiation and progression. Managing and controlling inflammatory diseases requires reducing inflammation to acceptable normal values. Non-toxic ways such as non-steroidal anti-inflammatory drugs, anti-inflammatory diets, and regular exercise allow such reduction in inflammation to normal values, thereby slowing down or arresting disease progression and allowing the discontinuation or reduction of toxic anti-inflammatory therapy while maintaining low inflammation using non-toxic therapy.

    PULMONARY INTERSTITIAL PNEUMONIA TREATMENT
    19.
    发明申请

    公开(公告)号:US20170151265A1

    公开(公告)日:2017-06-01

    申请号:US15428595

    申请日:2017-02-09

    Applicant: Kaplesh Kumar

    Inventor: Kaplesh Kumar

    CPC classification number: A61K31/573 A61K31/52 A61K31/616

    Abstract: Model and method of treating inflammatory diseases. Traditional treatments for such diseases include administering to the patient toxic and-inflammatory drugs. Following stabilization of the symptoms, the drug doses are tapered down to minimize side effects, as a result of which inflammation remains high and the disease is rarely cured. A chemistry-based disease model concludes that irrespective of the role that inflammation plays in the disease, inflammation reduction will impede disease initiation and progression. Managing and controlling inflammatory diseases requires reducing inflammation to acceptable normal values. Non-toxic ways such as non-steroidal anti-inflammatory drugs, anti-inflammatory diets, and regular exercise allow such reduction in inflammation to normal values, thereby slowing down or arresting disease progression and allowing the discontinuation or reduction of toxic anti-inflammatory therapy while maintaining low inflammation using non-toxic therapy.

    INFLAMMATORY DISEASE MODEL AND METHOD OF TREATMENT
    20.
    发明申请
    INFLAMMATORY DISEASE MODEL AND METHOD OF TREATMENT 审中-公开
    炎症疾病模型和治疗方法

    公开(公告)号:US20130143852A1

    公开(公告)日:2013-06-06

    申请号:US13627955

    申请日:2012-09-26

    Applicant: Kaplesh Kumar

    Inventor: Kaplesh Kumar

    CPC classification number: A61K31/573

    Abstract: Model and method of treating inflammatory diseases. Traditional treatments for such diseases include administering to the patient toxic anti-inflammatory drugs. Following stabilization of the symptoms, the drug doses are tapered down to minimize side effects, as a result of which inflammation remains high and the disease is rarely cured. A chemistry-based disease model concludes that irrespective of the role that inflammation plays in the disease, inflammation reduction will impede disease initiation and progression. Managing and controlling inflammatory diseases requires reducing inflammation to acceptable normal values. Non-toxic ways such as anti-inflammatory diets and regular exercise allow such reduction in inflammation to normal values, thereby slowing down or arresting disease progression and allowing reduction in the required anti-inflammatory drug maintenance dose.

    Abstract translation: 治疗炎性疾病的模型和方法。 用于这种疾病的传统疗法包括向患者施用有毒的抗炎药物。 在症状稳定之后,药物剂量逐渐减小,以尽量减少副作用,其结果是炎症仍然很高并且疾病很少被治愈。 基于化学的疾病模型得出结论,不管炎症在疾病中的作用如何,减少炎症将阻碍疾病的发生和发展。 治疗和控制炎性疾病需要将炎症减少到可接受的正常值。 诸如抗炎饮食和常规运动之类的无毒方法使得炎症减少到正常值,从而减慢或阻止疾病进展并允许减少所需的抗炎药物维持剂量。

Patent Agency Ranking